Otolaryngology: Open Access
Open Access

Pharyngitis; Tonsillitis; Skin infection; Anti-streptomycin; Serology; Acute rheumatic fever; Group A streptococcal infection

Introduction

One of the most typical infections seen in primary care clinics is acute pharyngitis. The typical symptoms of group a beta haemolytic streptococcus (GABHS) pharyngitis are only present in 20–30% of individuals. Clinical judgement alone has a low predictive value and causes diseases to be overestimated by 80% to 95%. Therefore, the results of throat cultures, epidemiological factors, signs, and symptoms, as well as other information, are used to inform diagnostic techniques for acute GABHS pharyngitis (TCs) [1]. Numerous studies have demonstrated that using a throat culture results in the more prudent use of antibiotics. In high-income countries, 6-8% of annual visits to primary care physicians and paediatric emergency departments are for acute pharyngitis. While viruses are the primary cause of the majority of acute pharyngitis cases, GAS infections account for 20–40% of cases. The prescription of an antibiotic in 60–70% of children who appear with acute pharyngitis suggests that proper diagnostic testing is not always carried out and that antimicrobial stewardship may be improved. The high incidence suggests that stewardship impact could be substantial [2].

In the pre-antibiotic period, puerperal group A streptococcal (GAS) infections were a significant contributor to per partum morbidity and mortality. From the 1940s through the 1980s, there was a consistent decline in the prevalence of these infections, which coincided with a general decline in invasive GAS infections (necrotizing fasciitis, myositis, and streptococcal toxic shock) during that time. Sadly, over the past 25 years, dangerous puerperal GAS infections and other invasive GAS infections have returned, and these diseases must now be taken into consideration when making a postpartum sepsis differential diagnosis. Even though they are still uncommon, such infections need to be identified and rapidly treated to avoid serious morbidity or mortality. We discuss our recent, single-institution experience with four GAS per partum patients that occurred over a five-year period, three of which were life-threatening puerperal sepsis and a fourth necrotizing cervicitis brought on by GAS. Here, we examine recent research that is pertinent to this developing issue [3].

The signs and symptoms of viral and GAS pharyngitis are difficult to distinguish from one another, and even the most skilled doctor has trouble doing so. To help doctors predict GAS infection, clinical prediction algorithms have been devised, however their efficacy is insufficient to guide treatment without culture. A throat swab cultured on selective agar is the gold standard for diagnosing GAS pharyngitis. Culture has a sensitivity of around 90% to 95% and a specificity of about 99%, but it needs 18 to 24 hours to incubate, preventing judgments about point-of-care treatment and necessitating a second encounter with the patient to deliver data [4].

Rapid antigen-detecting tests (RADT) for the diagnosis of GAS have varying sensitivity (66%-99%) but excellent specificity (around 95%). The extent of the disease, the size of the bacterial inoculum that was acquired on the swab and operator effect on testing methodology all affect sensitivity. The diagnostic performance of technologists is much better when nursing personnel and laboratory technicians execute the same RADT, with a difference in sensitivity ranging from 14% to 34% between groups. This can be because of the operator's experience, adherence to the test procedure, familiarity with reading RADTs, or other unknown factors [5]. The clinical utility could be decreased by this operator impact. The RADT is primarily made for testing simplicity; therefore operator involvement should be kept to a minimum. When a patient complains of acute pharyngitis, doctors often prescribe antibiotics out of worry that the patient may have GABHS infection, which if untreated could lead to suppurative consequences like tonsillar abscess or non-suppurative problems like rheumatic fever. However, antibiotics only slightly improve the symptoms of GABHS sore throat. On average, they only reduce the length of the symptoms by a day and a half. Recurrence of streptococcal pharyngitis is a common indicator of treatment failure [6]. These failure most likely results from the infection of bacteria that carry M protein, a virulence factor found on the surface of the bacterial wall that confers resistance to widely used antibiotics, in roughly 20% of children with GABHS. The failure of this treatment was not avoided by more recent betalactamase- resistant drugs. A review of the literature from 1945 to 1999, which included 10,484 instances of GABHS sore throat, revealed that antibiotic treatment only partially prevented sinusitis and acute otitis media, two common complications of this illness. When compared to placebo, rheumatic fever, a non-suppurative consequence, was reduced by less than 33% [7].

Material and Methods

Prior to the start of the investigation, the local research ethics board granted ethics and institutional approvals. Consistent kids who presented to the emergency department at Janeway Children's Hospital in St. John's, Newfoundland, Canada during November 2015 to January 2016 with suspected pharyngitis were enrolled in the study with parental permission. The only factor ruling someone out was their existing antibiotic regimen. The triage nurse identified the kid as possibly having pharyngitis during triage evaluation (based on history without physical examination), and parent or guardian agreement was acquired for participation. The ER doctor would next evaluate the youngster and do a physical exam. A single triplicate pharyngeal swab collection utilising three Copan eSwabs (Copan Diagnostics Inc., California, and USA) held together would be performed by the doctor if pharyngitis was detected. Two swabs were submitted to the microbiology laboratory for the technicians to do the RADT and conventional culture, and one swab was used to perform the RADT in the emergency department. The doctors decided on the course of treatment on their own [8].

Using a standard protocol, we were able to identify from our computerised data base 107,840 patients, ranging in age from 6 months to 18 years, who had been seen by their primary care physician between January 1, 1999, and December 31, 2000, for upper respiratory tract infection, tonsillitis, pharyngitis, sore throat, tonsillopharyngitis, neck pain, cervical lymphadenopathy, PTA, and RPA. Then, removing all children who were identified as having viral upper respiratory infections, we examined the charts of 78,473 of these kids who were identified as having an infected throat or one of the differential variants. Of these patients, 47,000 received an official diagnosis of acute tonsillitis or acute pharyngitis along with an antibiotic prescription, showing that their doctor had a suspicion of bacterial illness. According to the modified Centor criteria used in this study and the Nadir modified Breese Epidemiological and Clinical Score Card (ECSC), which has a 91% sensitivity and 98% specificity when the score was above 15 (score between 4 and 36) for the diagnosis of GABHS, 35,000 of these kids had at least four out of the five symptoms in the index visit. To see if throat swabs were done, the records of these kids were examined. On typical blood agar plates, these swabs were cultivated. Using a latex bead agglutination test, colonies that produced beta-haemolysis were classified for surface carbohydrate measurement [9].

Discussion

We examined the impact of the operator on RADT performance in the paediatric emergency department and discovered no statistically significant difference between nurses and techs. The prevalence of GAS was comparable to studies of a similar kind, where detection rates of GAS ranged from 22% to 38%. Despite reaching our planned sample size, our investigation was underpowered to detect a meaningful difference since we observed a smaller operator effect than anticipated from prior literature. The estimated difference in sensitivity between technologist- and nurse-performed RADT was used to determine the appropriate sample size. Our sample size was too small to draw a statistically significant result since we computed the sample size as the total number of specimens when the total number of positive specimens should have been used [10].

This study discovered relatively low parent/child adherence to antibiotic therapy for tonsillopharyngitis caused by symptomatic, culture-positive GABHS. Only 10% of kids started any kind of treatment at all, and only 10% finished the entire course. Although the cause of this poor compliance rate is unknown, it is consistent with other published studies. We hypothesise that a significant part of noncompliance is due to parents' perceptions that antibiotics are overprescribed and possibly hazardous. Despite this poor compliance, there was a very low rate of suppurative consequences in both our trial and others [11].

Despite the poor adherence, we also discovered no rise in the prevalence of acute rheumatic fever, the most dreaded GABHS consequence, in our patients. According to the epidemiological division of the Israeli Ministry of Health, the frequency of RF in our area has actually decreased since 2000, falling from 2.2 per 100,000 to 0.2 per 100,000 in 2008. This is consistent with the recommendations made for 10 days of antibiotic treatment for GABHS in other developed nations, including the United States. Since the 1950s, the prevalence of RF has steadily decreased there. Currently, there are only 10 cases of RF per 100,000 patients with GABHS pharyngitis, and only 1 case of rheumatic heart disease occurs in every 10,000 patients with acute rheumatic fever. In fact, despite the drop in acute rheumatic fever, GABHS recurrence increased in the USA concurrent with the increased use of antibiotics, rising from 9% and 10.7% in the years 1975 to 1979, respectively, to 25.9% and 37.5% in the years 1995 to 1996.

Based on proxy indicators of GABHS eradication from the tonsillopharynx, the 1950s saw the introduction of the 10-day oral penicillin prescription, which replaced intramuscular injections of long-acting parenteral penicillin. No study, however, has definitively demonstrated that this treatment definitely prevents acute rheumatic fever. Although orally prescribed penicillin appeared to be equally effective for clinical and laboratory resolution of signs and symptoms, it is difficult to administer and costly, especially when you consider the staggering financial burden of about 140 office visits annually per 1,000 children under the age of 15. It was discovered that using azithromycin or cephalosporins instead of penicillin led to superior bacteriological and clinical outcomes and required a shorter duration of therapy [12].

Conclusion

According to our research, most parents and patients who have children with GABHS quit giving them antibiotics before the required course is finished. They seem to stop as soon as the symptoms go away. This "incorrect" use doesn't seem to have any harmful effects. We think there is room to cut back on both the frequency and duration of antibiotic use. Antibiotics could be used more wisely to reduce expenses, increase compliance, and make life easier for both parents and kids. In a large, multisite collection of isolates, this investigation showed the incidence of resistance to popular antibiotics used for the prevention or treatment of GBS infections.

We discovered that all invasive GBS isolates examined were susceptible to cefazolin and vancomycin, second-line medications advised for use in IAP candidates who report penicillin allergies, as well as penicillin and ampicillin, the first-line medications advised for IAP. Contrarily, GBS resistance to erythromycin (25.6%) and clindamycin (12.7%) was widespread. Clindamycin resistance was found in 14.9% of early-onset patient isolates and erythromycin resistance was found in 21.2%. The 2002 guidelines recommending susceptibility testing of isolates from IAP candidates with penicillin allergy are supported by our findings, which are consistent with earlier studies in the literature. Of note, certain medical professionals do not advocate utilising erythromycin for IAP due to reports of sub therapeutic amounts in foetal serum and amniotic fluid. Clinicians choosing empiric regimens to treat GBS illness should be mindful of the possibility for MLS resistance.

Acknowledgement

None

Conflict of Interest

None

1. Van Brusselen D, Vlieghe E, Schelstraete P (2014) Streptococcal pharyngitis in children. Eur J Pediatr 173:1275-1283.

Google Scholar, Crossref, Indexed at

2. Shaikh N, Swaminathan N, Hooper EG (2012) Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children. J Pediatr 160: 487-493.

Google Scholar, Crossref, Indexed at

3. Fox JW, Cohen DM, Marcon MJ, Cotton WH, Bonsu BK (2006) Performance of rapid streptococcal antigen testing varies by personnel. J Clin Microbiol 44: 3918-3922.

Google Scholar, Crossref, Indexed at

4. Little PS, Williamson I (1994) Are antibiotics appropriate for sore throats? Costs outweigh the benefits. BMJ 309: 1010-1011.

Google Scholar, Crossref, Indexed at

5. Pichichero ME (1998) Group A beta-hemolytic streptococcal infections. Am Acad Pediatr 9:291-302.

Google Scholar, Crossref, Indexed at

6. Schaad UB (2004) acute streptococcal tonsillopharyngitis. Int J Med Res 32: 1-13.

Google Scholar, Indexed at

7. Kelsen JR, Sullivan KE, Rabizadeh S (2019) NASPGHAN position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease (VEO-IBD) Judith. J Pediatr Gastroenterol Nutr 70: 1.

Google Scholar, Crossref, Indexed at

8. Trehan I, Fritz SA (2009) Group B Streptococcus vertebral osteomyelitis-discitis in an immunocompetent adolescent. J Pediatr Infect Dis 28: 552-553.

Google Scholar, Crossref, Indexed at

9. Rudolph K, Bruce M, Bruden D (2016) Epidemiology of invasive group a streptococcal disease in Alaska. J Clin Microbiol 54: 134-141.

Google Scholar, Crossref, Indexed at

10. Lin FYC, Azimi PH, Weisman LE (2000) Antibiotic susceptibility profiles for group B streptococci isolated from neonates. Clin Infect Dis 31: 76-79.

Google Scholar, Crossref, Indexed at

11. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR (2001) Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 134: 506-508.

Google Scholar, Crossref, Indexed at

12. Arisoy AS, Altinişik B, Tunger O, Kurutepe S, Ispahi O, et al. (2003) Maternal carriage and antimicrobial resistance profile of group B Streptococcus. Infection 31: 244-246.

Google Scholar, Crossref, Indexed at